Evidence map›Paper›PMID 28329242›Full record

ArticleThe Journal of infectious diseases2017

Lethal CD4 T Cell Responses Induced by Vaccination Against Staphylococcus aureus Bacteremia.

Hatice Karauzum, Christian C Haudenschild, Ian N Moore, Mahta Mahmoudieh, Daniel L Barber, Sandip K Datta

Abstract read
In one paragraph

Article in The Journal of infectious diseases, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Review
  2. Overcoming Immune Evasion inACS infectious diseases · 2025
    Review
  3. Article
  4. Article
  5. Conserved moonlighting protein pyruvate dehydrogenase induces robust protection againstProceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  6. Superantigens promoteProceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  7. Observational
  8. Article
  9. Evasion of Immunological Memory byFrontiers in immunology · 2021
    Review
  10. Article
  11. Review
  12. Article
  13. Immunity toMicrobiology spectrum · 2019
    Review
  14. TBAScientific reports · 2019
    Article
  15. Article
  16. Article
  17. Two Vaccines formSphere · 2018
    Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Hatice KarauzumBacterial Pathogenesis Unit, LCID, NIAID, NIH, Bethesda, Maryland, United States of America
Christian C HaudenschildBacterial Pathogenesis Unit, LCID, NIAID, NIH, Bethesda, Maryland, United States of America
Ian N MooreInfectious Disease Pathogenesis Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.
Mahta MahmoudiehBacterial Pathogenesis Unit, LCID, NIAID, NIH, Bethesda, Maryland, United States of America
Daniel L BarberT-Lymphocyte Biology Unit, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, MD 20892, USA.
Sandip K DattaBacterial Pathogenesis Unit, LCID, NIAID, NIH, Bethesda, Maryland, United States of America

Funding

Host Immunity Against BacteriaZIAAI001043 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI MYLES, IAN · 2009 to 2025
$18.9M
Immune Regulation in Mycobacterial InfectionsZIAAI001171 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI BARBER, DANIEL · 2012 to 2025
$16.7M
6 · The paper itself

Abstract

Multiple candidate vaccines against Staphylococcus aureus infections have failed in clinical trials. Analysis of a recent prematurely halted vaccine trial revealed increased mortality rates among vaccine recipients in whom postsurgical S. aureus infection developed, emphasizing the potential for induction of detrimental immune responses and the need to better understand the requirements for protective immunity against S. aureus. These failures of single-antigen vaccines have prompted ongoing development of multicomponent vaccines to target the multitude of S. aureus virulence factors. In the current study, we used lethally irradiated S. aureus as a model multicomponent vaccine and showed that vaccination of mice decreased survival in a bacteremia challenge model. These deleterious effects were due to a CD4 T-cell-dependent interferon γ response and could be prevented by inhibiting development of this response during vaccination. Our results identify the potential for vaccination to induce pathological immune responses, and they have implications for recent vaccine failures and the design of future staphylococcal vaccines.

Indexed as

AnimalsBacteremiaFemaleInterferon-gammaMethicillin-Resistant Staphylococcus aureusMiceMice, Inbred C57BLMice, KnockoutStaphylococcal InfectionsStaphylococcal VaccinesTh1 CellsInterferon-gammaStaphylococcal VaccinesIFN-γ;immunopathology.Staphylococcus aureussystemic infectionTh1 cellsvaccination

Identifiers

PMID28329242
PMCPMC5853805

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.